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ABSTRACT 
 
Comparison of Antibacterial Activity of 
Ozonated Olive Oil and Chlorhexidine Gluconate 
 
by 
 
Changmin Lee 
 
Master of Science, Graduate Program in Periodontics 
Loma Linda University, December 2017 
Dr. Tord Lundgren, Chairperson 
 
 
Aim: The aim of this in vitro disk diffusion susceptibility test is to compare the 
antibacterial activity of ozonated olive oil (OzOO) with chlorhexidine gluconate 
(CHX) against periodontal pathogens, Porphyromonas gingivalis and Aggregatibacter 
Actinomycetemcomitans. 
Materials and Methods: The antibacterial activity of two antiseptics, OzOO and 
CHX, and, two controls, olive oil and normal saline was assessed by disk diffusion 
susceptibility test. For disk diffusion susceptibility test, two periodontal pathogens, 
20 petri dishes for P. gingivalis and 18 petri dishes for A. actinomycetemcomitans, 
were used. To assess the antibacterial activity, the diameters of the growth 
inhibition zone were measured with a caliper. 
Results: The diameters of the growth inhibition zone against P. gingivalis were 31.4 
± 5.05 mm for OzOO and 20.9 ± 1.19 mm for CHX (p<0.001). The diameters of the 
growth inhibition zone against A. actinomycetemcomitans were 25.9 ± 1.69 mm for 
OzOO and 18.4 ± 1.55 mm for CHX (p<0.001). All the measured diameters for olive 
oil and normal saline against both periodontal pathogens were 6 mm, with no sign 
of the growth inhibition. 
ix 
Conclusion: The antibacterial activity of OzOO against P. gingivalis and A. 
actinomycetemcomitans is superior to that of CHX.
1 
CHAPTER ONE 
INTRODUCTION AND REVIEW OF THE LITERATURE 
 
In the mouth, teeth provide hard and non-shedding surfaces for the 
development of bacterial deposits. This bacterial colonization, dental plaque, is 
considered as the primary cause of periodontal disease and caries. Hundreds of 
different bacterial species are found in dental plaque. Among these bacteria, three 
red complex bacteria, Porphyromonas  gingivalis, Treponema denticola and 
Tannnerella forsythia and Aggregatibacter actinomycetemcomitnas are believed to 
be the major etiologic elements for the development of periodontal disease (1). 
These species have been recognized as the important periodontal pathogens in 
many scientific articles and also in the consensus report from the World Workshop 
of Periodontology (2). 
The primary goal in the treatment of periodontal disease is the anti-infective 
therapy to eliminate oral pathogens, stop disease progression and maintain the 
long-term periodontal stability. Therapeutic regimes to achieve these aims include 
various combinations of oral hygiene techniques, scaling and root planing (SRP) as 
an initial non-surgical treatment, surgical elimination of periodontal pockets and 
anatomical defects, and, correction of inadequate dental restorations which aid 
bacterial retention and interfere with plaque removal. 
The bacterial etiology of periodontal disease (3-5) and the hypothesis that 
specific bacteria are involved (6) have intensified the interest of using anti-bacterial 
agents as a complement to non-surgical and surgical periodontal therapy (7, 8). 
Among anti-bacterial agents, chlorhexidine gluconate (CHX) is often used as the 
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local vehicle. It has shown to inhibit the growth of various bacterial species isolated 
from subgingival plaque (9). Clinically, it has been widely used, as the antiseptic 
agent in the mouthrinse. Clinical trials also have been performed with daily use of 
CHX mouthrinse for up to 2 years (10, 11). In addition, a CHX chip product is also 
available as an adjunct to SRP (12, 13).  
However, the prolonged use of CHX may cause epithelial desquamation, 
tooth staining, altered taste sensation, impairment of wound healing and reduced 
attachment of fibroblasts to root surfaces (14, 15).  
Ozone is currently discussed as a possible alternative oral antiseptic agent 
with fewer side effects. Ozone is bactericidal, anti-viral and anti-fungal. When ozone 
is infused into unsaturated oil such as olive oil, it becomes ozonated olive oil (OzOO) 
and releases hydrogen peroxide. OzOO has been reported to be used topically for 
the treatment of war wounds, gingivitis, abscess, anaerobic and herpetic infections, 
fungal disease, trophic ulcers and burns, anal fissures, furunculosis and vulvo-
vaginitis (16, 17). It has been hypothesized that the action of ozonated oil on wound 
healing may be connected in part to its antimicrobial effect but also to its ability to 
promote some growth factors, activate local anti-oxidant mechanisms and promote 
tissue repair (18). 
Clinical effects of topical application of OzOO have also been reported. In one 
study, the efficacy of OzOO on free gingival graft surgical wounds was evaluated. A 
significant improvement in epithelial healing and gingival health after topical 
application to the surgical sites was reported (19). Also, the efficacy of OzOO as a 
3 
mono-therapy and an adjunct to SRP in the treatment of chronic periodontitis 
improved the periodontal conditions (20). 
In another study, OzOO showed significantly greater growth inhibition 
against P. gingivalis and Staphylococcus aureus than 0.2% CHX, using a disk diffusion 
susceptibility test (21). However, the evidence of OzOO as an alternative to CHX is 
still lacking. To evaluate the antibacterial activity for both chronic and aggressive 
periodontitis, the effect of OzOO and CHX on red complex bacteria and A. 
actinomycetemcomitans should be assessed. In addition, the effect of another 
commercially available OzOO and CHX should be assessed. 
The aim of this in vitro disk diffusion susceptibility test is to compare the 
antibacterial activity of a commercially available OzOO with CHX against two 
periodontal pathogens, P. gingivalis and A. actinomycetemcomitans. The null 
hypothesis is that there is no significant difference of the antibacterial activity 
between two antiseptics, OzOO and CHX, against two periodontal pathogens, P. 
gingivalis and A. actinomycetemcomitans. 
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CHAPTER TWO 
MATERIAL AND METHODS 
 
Microbial Species 
Freeze-dried bacteria were obtained from Division of Microbiology and 
Molecular Genetics, School of Medicine, Loma Linda University. The bacteria strains 
were: P. gingivalis ATCC®  33277TM and A. actinomycetemcomitans ATCC®  33384 TM. 
 
Culture Conditions 
Frozen and isolated P. gingivalis was inoculated into the culture tube 
containing Brain-Heart Infusion (BHI) medium consisted of 18.5 g dehydrated BHI, 
5 ug/ml hemin, 100 ul vitamin K, 2.5 g yeast extract and 0.5 g DL-cystein. Then the 
tube was incubated at 37˚c under anaerobic conditions (5% CO2, 10% H2, 85% N2) 
for 24 hours. 
Frozen and isolated A. actinomycetemcomitans was also inoculated in the 
culture tube having same medium and incubated at 37˚c under the same anaerobic 
conditions for 24 hours. 
 
Antiseptics 
The following antiseptics were tested: OzOO (PurO3® , Promolife Inc., 
Fayetteville, AR, USA) with a peroxide value of 224 meq/Kg (Figure 1), and, 0.12% 
CHX (Peridex® , 3M ESPE, St. Paul, MN, USA). 
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Figure 1. Ozonated olive oil (PurO3® , Promolife Inc., Fayetteville, AR, USA) 
 
In addition to these two antiseptics, two control groups were tested: Olive oil 
(Promolife Inc., Fayetteville, AR, USA), and, normal saline (0.9% Sodium Chloride 
Irrigation, USP® , Baxter, Irvine, CA, USA). 
 
Disk Diffusion Susceptibility Test 
6 mm-diameter sterile disks (Antibiotic Sensitivity Disks, Blank, Sterile® , 
Carolina Biological Supply Company, Burlington, NC, USA) (Figure 2) were prepared 
and impregnated with two test groups, OzOO and CHX, and two control groups, olive 
oil and normal saline. 50 ul of each group was impregnated into each disk using a 
micropipette. Semi solid-liquid OzOO was warmed up in the heating bath circulator 
to be converted into liquid immediately prior to impregnation for ease of 
application. Then, all the sterile disks were kept for 24 hours for fully impregnation 
in room temperature. 
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Figure 2. 6 mm-diameter sterile disk (Antibiotic Sensitivity Disks, 
Blank, Sterile® , Carolina Biolgical Supply Company, Burlington, NC, 
USA) 
 
 
Microbial suspensions, P. gingivalis and A. actinomycetemcomitans, were 
aseptically spread on the 20 petri dishes for P. gingivalis and 18 petri dishes for A. 
actinomycetemcomitans, respectively. Each dish contained BHI agar consisted of 
18.5 g dehydrated BHI, 5 ug/ml hemin, 100 ul vitamin K, 2.5 g yeast extract, 0.5 g 
DL-cystein and 10 g bacto agar. 
Previously impregnated sterile disks were placed onto BHI agar surface. In 
one petri dish, four disks impregnated with each group, OzOO, CHX, olive oil and 
normal saline respectively, were placed onto each quadrant. Overall, 144 total 
sterile disks were used for this in vitro study. 
All the petri dishes spread with P. gingivalis and A. actinomycetemcomitans 
respectively with four disks were then incubated at 37˚c under anaerobic conditions 
(5% CO2, 10% H2, 85% N2) for 48 hours. 
7 
The antibacterial activity was assessed by measuring the diameters of the 
growth inhibition zone surrounding each disk with a caliper in millimeters, after 48 
hours of incubation period. When the shape of the growth inhibition zone 
surrounding disks was not a circle, the shortest and longest diameters were 
measured and the mean measurement was calculated as a representative diameter. 
 
Statistical Analysis 
The diameters of the growth inhibition zone of four groups against for each 
microbial suspension, P. gingivalis and A. actinomycetemcomitans were compared 
using Kruskal-Wallis test at alpha level of 0.05. Since there was no effect of olive oil 
and normal saline, a paired t-test was used to compare the effect of OzOO and CHX 
on each microbial suspension, P. gingivalis and A. actinomycetemcomitans at alpha 
level of 0.05. 
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CHAPTER THREE 
RESULTS 
 
The diameters of the growth inhibition zone of all groups against P. gingivalis 
and A. actinomycetemcomitans were measured. The mean and standard deviation 
(SD) of all petri dishes are presented in Tables 1, 2 and 3. 
The mean ± SD diameters of the growth inhibition zone against P. gingivalis 
were 31.4 ± 5.05 mm for OzOO, and, 20.9 ± 1.19 mm for CHX (Figure 3 and 4). The 
mean ± SD diameters of the growth inhibition zone against A. 
actinomycetemcomitans for OzOO and CHX were 25.9 ± 1.69 mm and 18.4 ± 1.55 
mm respectively (Figure 3-8). All the measured diameters for olive oil and normal 
saline against both microbial suspensions were 6 mm, same as the diameter of a 
sterile disk, with no sign of the growth inhibition (Figure 5-8). 
While the growth inhibition zone for CHX was a full circle shape in all petri 
dishes, it was not always for OzOO. In addition, the growth inhibition zone for OzOO 
and CHX against A. actinomycetemcomitans was fully and/or partially blurred 
(Figure 7, 8). The growth inhibition zone for OzOO was not fully clear but blurred, 
and the degree of blurring varied between petri dishes. The growth inhibition zone 
for CHX was a clear circle with a blurred edge. 
Kruskal-Wallis test showed a significant difference of the growth inhibition 
zone between the groups. A paired t-test was conducted to compare the growth 
inhibition zone for OzOO and CHX against both P. gingivalis and A. 
actinomycetemcomitans. For both microbial suspensions, there was a significant 
difference between two groups with p<0.001 (Table 4). 
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Table 1. Diameters in millimeters of the growth inhibition zone for OzOO, CHX, 
olive oil and normal saline against P. gingivalis 
 
 
 
 
 
 
 
 
 
No. of 
petri dish 
Diameter 
CHX 
OzOO 
Olive oil 
Normal  
saline Short Long Mean 
1 21.2 30.3 38.6 34.5 6 6 
2 21.8 31.0 41.5 36.3 6 6 
3 23.5 33.8 47.1 40.5 6 6 
4 21.7 29.7 39.2 34.5 6 6 
5 21.7 31.9 47.6 39.8 6 6 
6 21.3 31.3 41.2 26.3 6 6 
7 20.0 25.6 29.1 27.4 6 6 
8 20.3 28.6 29.3 29.0 6 6 
9 22.2 32.6 25.9 34.3 6 6 
10 19.4 28.2 31.3 29.8 6 6 
11 19.5 26.5 28.1 27.3 6 6 
12 19.4 24.5 25.9 25.2 6 6 
13 19.7 29.8 32.4 31.1 6 6 
14 19.4 28.8 29.6 29.2 6 6 
15 22.0 31.2 31.7 31.5 6 6 
16 19.6 18.8 18.8 18.8 6 6 
17 21.7 32.0 33.6 32.8 6 6 
18 21.8 29.7 31.6 30.7 6 6 
19 20.0 23.5 32.3 27.9 6 6 
20 20.8 32.1 32.1 32.1 6 6 
10 
Table 2. Diameters in millimeters of the growth inhibition zone for OzOO, CHX, 
olive oil and normal saline against A. actinomycetemcomitans 
 
No. of 
petri 
dish 
Diameter 
CHX 
OzOO 
Olive oil 
Normal  
saline Short Long Mean 
1 19.1 26.7 26.7 26.7 6 6 
2 20.0 24.1 24.1 24.1 6 6 
3 18.9 26.1 26.1 26.1 6 6 
4 19.9 27.8 27.8 27.8 6 6 
5 18.4 26.9 26.9 26.9 6 6 
6 20.0 24.5 24.5 24.5 6 6 
7 20.9 27.2 27.2 27.2 6 6 
8 18.9 27.9 27.9 27.9 6 6 
9 17.2 20.9 21.4 21.2 6 6 
10 18.2 22.1 29.0 25.6 6 6 
11 17.8 25.0 27.3 26.2 6 6 
12 18.5 22.1 25.8 24.0 6 6 
13 18.2 24.5 26.6 25.6 6 6 
14 20.1 26.2 28.0 27.1 6 6 
15 15.8 27.0 27.0 27.0 6 6 
16 15.6 24.0 25.6 24.8 6 6 
17 18.1 24.6 28 26.3 6 6 
18 15.8 22.1 32.5 27.3 6 6 
 
 
 
Table 3. Mean diameter and SD of the growth inhibition zone for OzOO, CHX, olive 
oil and normal saline against P. gingivalis and A. actinomycetemcomitans  
 
Antiseptic 
P. gingivalis A. actinomycetemcomitans 
Mean SD Mean SD 
CHX 20.9 1.19 18.4 1.55 
OzOO 31.4 5.05 25.9 1.69 
Olive oil 6 0 6 0 
Normal 
saline 
6 0 6 0 
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Figure 3. Bar chart of the mean diameter of the growth inhibition zone with 
error bars representing SD for OzOO and CHX against P. gingivalis and A. 
actinomycetemcomitans 
 
 
 
 
 
 
12 
 
Figure 4. Box-and-whisker plot of the mean diameter of the growth inhibition 
zone with median, 25% and 75% quartiles, and, minimum and maximum for 
OzOO, CHX, olive oil and normal saline against P. gingivalis and A. 
actinomycetemcomitans 
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Figure 5. Petri dish (dish no. 12) for P. gingivalis, upper left quadrant – sterile 
disk impregnated by normal saline, upper right quadrant – sterile disk 
impregnated by CHX, lower right quadrant – sterile disk impregnated by olive oil, 
lower left quadrant – sterile disk impregnated by OzOO 
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Figure 6. Petri dish (dish no. 12) for P. gingivalis, for measuring the diameter, 
upper left quadrant – sterile disk impregnated by CHX, upper right quadrant – 
sterile disk impregnated by normal saline, lower right quadrant – sterile disk 
impregnated by OzOO, lower left quadrant – sterile disk impregnated by olive oil 
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Figure 7. Petri dish (dish no. 12) for A. Actinomycetemcomitans, upper left 
quadrant – sterile disk impregnated by normal saline, upper right quadrant – 
sterile disk impregnated by CHX, lower right quadrant – sterile disk impregnated 
by olive oil, lower left quadrant – sterile disk impregnated by OzOO 
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Figure 8. Petri dish (dish no. 15) for A. Actinomycetemcomitans, upper left 
quadrant – sterile disk impregnated by normal saline, upper right quadrant – 
sterile disk impregnated by CHX, lower right quadrant – sterile disk impregnated 
by olive oil, lower left quadrant – sterile disk impregnated by OzOO 
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Table 4. Paired sample t-test to compare the antibacterial activity of OzOO and CHX 
against P. gingivalis and A. actinomycetemcomitans 
 
Bacteria Pair Mean SD SE 
95% Confidence 
Interval of the 
Difference t df Sig 
(2-tailed) 
Lower Upper 
P. gingivalis 
OzOO - 
CHX 
10.6 4.19 0.94 8.61 12.53 11.30 19 .000 
A. 
actinomycetmocomitans 
OzOO - 
CHX 
7.5 2.12 0.50 6.43 8.53 14.97 17 .000 
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CHAPTER FOUR 
DISCUSSION 
 
Comparing the diameters of the growth inhibition zone for CHX and OzOO 
against P. gingivalis and A. actinomycetemcomitans, the antibacterial activity of 
OzOO was greater than that of CHX with a statistical significance (p<0.001). Based 
on the results, this study indicates that OzOO may be an alternative to CHX as an 
antiseptic agent. 
Two important findings should be considered in this study. At first, the shape 
of the growth inhibition zone of OzOO against both microbials was not always a full 
circle. The possible reason is the uneven and/or incomplete distribution of OzOO 
into the sterile disk during the disk impregnation period resulting in uneven 
distribution of OzOO into microbial suspensions during the incubation period. In 
addition, when semi solid-liquid OzOO was warmed up in the heating bath circulator 
to be converted into liquid for disk impregnation, the amount of peroxide can be 
potentially lost. The second noticeable finding was the fully and/or partially blurred 
growth inhibition zone for OzOO and CHX against A. actinomycetemcomitans, being 
interpreted as the partial antibacterial activity. It is difficult to compare the degree 
of partial antibacterial activity, because the degree of blurring was different. The 
degree of blurring for OzOO varied between petri dishes. It was also different from 
the degree of blurring for CHX. The growth inhibition zone for CHX was a clear circle 
with a blurred edge. The possible reasons of the blurred growth inhibition zone are 
the potential regrowth of A. actinomycetemcomitans during the incubation period 
and non-purified A. actinomycetemcomitans itself. 
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There are various methods to evaluate the antibacterial activity; diffusion 
method, dilution method, thin-layer chromatography bioautography, time-kill test, 
ATP bioluminescence assay and flow cytofluorometric method (22, 23). Disk 
diffusion susceptibility test, one of the diffusion methods, was used in this in vitro 
study. Disk diffusion susceptibility test assesses the antimicrobial activity by 
measuring the diameters of the growth inhibition zone surrounding each disk with a 
caliper in millimeters. This test is widely used because of its simplicity, easy 
interpretation, flexibility in disk selection and low cost, though it is lacking 
mechanization or automatization. For the interpretation of the test, the result can be 
analyzed in two ways, both qualitatively and quantitatively. By the CLSI guideline 
(Clinical and Laboratory Standards Institute, formerly National committee for 
Clinical Laboratory Standards, NCCLS), there are 3 categories, susceptible, 
intermediate or resistant based on the standard diameter of each antibiotic for the 
qualitative interpretation (24). However, the qualitative interpretation from the 
result of this in vitro study was difficult because CLSI guideline doesn’t give any 
information about OzOO and CHX, used in this study. Minimal inhibitory 
concentration (MIC) is evaluated for the quantitative interpretation. However, 
determining the exact MIC is not appropriate through disk diffusion susceptibility 
test, because it is difficult to quantify the amount of diffused antimicrobial agent. 
Therefore, in this in vitro study, only the diameter of the growth inhibition zone was 
compared to evaluate the antibacterial activity. 
In the consensus report from the World Workshop of Periodontology, P. 
gingivalis, A. actinomycetemcomitans and T. forsythia are considered to play the 
20 
major role in developing periodontal disease (2). As one of the red complex bacteria, 
P. gingivalis, Gram-negative anaerobic and non-motile rod, is elevated in the active 
lesions of destructive periodontal disease (2). A. actinomycetemcomitans, Gram-
negative facultative anaerobic and non-motile rod, is an important virulence factor 
in the pathogenesis of aggressive periodontitis with highly leukotoxic effects (25). 
Related to these bacterial species, periodontal disease, also being affected by other 
co-factors, is developed and destructing peridontium. 
To control periodontal disease, non-surgical treatment is usually performed 
to eliminate oral pathogens mechanically. Based on the series of studies, SRP 
favorably improved pocket depth (PD) and clinical attachment level (CAL) for both 
moderate and advanced periodontitis (26, 27). Microbiologically, SRP also reduced 
the amount of various bacterial species related to periodontal disease though they 
were still remained to some extent (28, 29). Therefore, 0.2% CHX mouthrinse was 
used following SRP for treating periodontitis and, it improved both PD and CAL in all 
initially different PD groups (14). Plus, CHX itself was also effective to reduce plaque 
index and gingival index in addition to the oral hygiene, toothbrushing and 
interdental cleansing (10). 
A new OzOO for tooth and gum support (PurO3™) is now available in the 
field of dentistry as an alternative to CHX with fewer side effects. OzOO is basically 
produced through the chemical reaction between ozone and olive oil. When ozone, 
activated oxygen, is funneled into a tube, an electrical charge is generated. During 
this process, ozone is slowly infused into olive oil and OzOO is created. For the 
physiochemical property, there is a chemical reaction, called ozonolysis, between 
21 
ozone and unsaturated fatty acid of olive oil, especially alkene (carbon-to-carbon 
double bonds) in fatty acid (19). In PurO3™, 224 meq/Kg of hydrogen peroxide is 
formed as a result of ozonolysis. In another study showing significant growth 
inhibition against P. gingivalis and S. aureus by OzOO (Novox® , MoSS, Italy), 560-
590 meq/Kg of hydrogen peroxide was formed by ozonolysis in OzOO (21). 
Regarding to the safety of ozone as an alternative antiseptic, it is important to 
understand the potential toxic effects of ozone. According to studies evaluating the 
cytotoxic effects of gaseous and aqueous ozone, aqueous ozone proved the highest 
level of biocompatibility on oral epithelial cells, gingival fibroblasts and periodontal 
cells (30, 31). 
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CHAPTER FIVE 
CONCLUSION 
 
Within the limits of this study, it is concluded that the antibacterial activity of 
OzOO against P. gingivalis and A. actinomycetemcomitans is superior to that of CHX. 
For the clinical use of OzOO as an alternative to CHX, other research such as in vivo 
and clinical study should be designed and planned. 
 
  
23 
REFERENCES 
 
1) Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL jr. Microbial complexes 
in subgingival plaque. J Clin Periodontol. 1998 Feb;25(2):134-44 
2) Consensus report. Periodontal diseases: Pathogenesis and microbial factors. 
Ann Periodontol. 1996  Nov;1(1):926-32 
3) Socransky SS. Relationship of bacteria to the etiology of periodontal disease. J 
Dent Res. 1970 Mar-Apr;49(2):203-22 
4) Slots J. Subgingival microflora and periodontal disease. J Clin Periodontol. 1979 
Oct;6(5):351-82 
5) Moore WE, Holdeman LV, Cato EP, Smibert RM, Burmeister JA, Ranney RR. 
Bacteriology of moderate (chronic) periodontitis in mature adult humans. Infect 
Immun 1983 Nov;42(2):510-5 
6) Loesche WJ, Syed SA, Schmidt E, Morrison EC. Bacterial profiles of subgingival 
plaques in periodontitis. J Periodontol. 1985 Aug;56(8):447-56 
7) Van der Ouderaa FJ. Anti-plaque agents. Rationale and prospects for prevention 
of gingivitis and periodontal disease. J Clin Periodontol. 1991 Jul;18(6):447-54 
8) Greenstein G. Supragingival and subgingival irrigation: Practical application in 
the treatment of periodontal diseases. Compendium. 1992 Dec:13(12):1098, 
1102, 1104 passim 
9) Stanley A, Wilson M, Newman HN. The in vitro effects of chlorhexidine on 
subgingival plaque bacteria. J Clin Periodontol. 1989 Apr;16(4):259-64 
10) Löe H, Schiött CR, Karring G, Karring T. Two years oral use of chlorhexidine in 
man. I. General design and clinical effects. J Periodontol Res. 1976 
Jun;11(3):135-44 
11) Fardal O, Turnbull RS. A review of the literature on use of chlorhexidine in 
dentistry. J Am Dent Assoc. 1986 Jun;112(6):863-9 
12) Soskolne WA, Heasman PA, Stabholz A, Smart GJ, Palmer M, Flashner M, 
Newman HN. Sustained local delivery of chlorhexidine in the treatment of 
periodontitis: A multi-center study. J Periodontol. 1997 Jan;68(1):32-8 
13) Jeffcoat MK, Bray KS, Ciancio SG, Dentino AR, Fine DH, Gordon JM, Gunsolley JC, 
Killoy WJ, Lowenguth RA, Magnusson NI, Offenbacher S, Palcanis KG, Proskin 
HM, Finkelman RD, Flashner M. Adjunctive use of a subgingival controlled-
release chlorhexidine chip reduced probing depth and improves attachment 
24 
level compared with scaling and root planing alone. J Periodontol. 1998 
Sep;69(9):989-97 
14) Christie P, Claffey N, Renvert S. The use of 0.2% chlorhexidine in the absence of 
a structured mechanical regimen of oral hygiene following the non-surgical 
treatment of periodontitis. J Clin Periodontol. 1998 Jan;25(1):15-23 
15) Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and 
antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 
6-month clinical trial. J Clin Periodontol. 2004 Oct;31(10):878-84 
16) Bocci V. Ozone: A new medical drug. Dordrecht: Springer, 2005;32-5, 102-3 
17) Tara F, Zand-Kargar Z, Rajabi O, Berenji F, Akhlaghi F, Shakeri MT, Azizi H. The 
effects of ozonated olive oil and coltrimazoe cream for treatment of 
vulvovaginal candidiasis. Altem Ther Heanth Med. 2016 Jul;22(4):44-9 
18) Oosting RS, Van Rees-Verhoef M, Verhoef J, Van Golde LM, Van Bree L. Effects of 
ozone on cellular ATP levels in rat and mouse alveolar macrophages. Toxicology. 
1991;70(2):195-202 
19) Patel PV, Kumar S, Vidya GD, Patel A, Holmes JC, Kumar V. Cytological 
assessments of healing palatal donor site wounds and grafted gingival wounds 
after application of ozonated oil: An eighteen-month randomized controlled 
clinical trial. Acta Cyto. 2012;56(3):277-84. Doi: 10.1159/000336889. Epub 
2012 Apr 26 
20) Patel PV, Patel A, Kumar S, Holmes JC. Effect of subgingival application of topical 
ozonated olive oil in the treatment of chronic periodontitis: A randomized, 
controlled, double blind, clinical and microbiological study. Minerva Stomatol. 
2012 Sep;61(9):381-98 
21) Montevecchi M, Dorigo A, Cricca M, Checchi L. Comparison of the antibacterial 
activity of an ozonated oil with chlorhexidine digluconate and povidone-iodine. 
A disk diffusion test. New Microbiol. 2013 Jul;36(3:289-302. Epub 2013 Jun 30 
22) Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial 
activity: A review. J of Pharmaceutical Analysis. 6 (2016) 71-79 
23) Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: A review of 
general principles and contemporary practices. Clin Infect Dis. 2009 Dec 
1;49(11):1749-55. doi: 10.1086/6479652 
24) Laboratory protocol: “Susceptibility testing of Enterobacteriaceae using disk 
diffusion”. WHO Global Food Infections Network. 2010 
25 
25) Haraszthy VI, Hariharan G, Tinoco EM, Cortelli JR, Lally ET, Davis E, Zambon JJ. 
Evidence for the role of highly leukotoxic Actinobacillus 
actinomycetemcomitans in the pathogenesis of localized juvenile and other 
forms of early-onset periodontitis. J Periodontol. 2000 Jun;71(6):912-22 
26) Badersten A, Nilvéus R, Egenberg J. Effect of nonsurgical periodontal therapy. I. 
Moderately advanced periodontitis. J Clin Periodontol. 1981 Feb;8(1):57-72 
27) Badersten A, Nilvéus R, Egenberg J. Effect of nonsurgical periodontal therapy. II. 
Severely advanced periodontitis. J Clin Periodontol. 1984 Jan:11(1):63-76 
28) Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr, Socransky SS. The effect of 
SRP on the clinical and microbiological parameters of periodontal diseases. J 
Clin Periodontol. 1997 May;24(5):324-34 
29) Loos B, Claffey N, Egelberg J. Clinical and microbiological effects of root 
debridement in periodontal furcation pockets. J Clin Periodontol. 1988 
Aug;15(7):453-63 
30) Huth KC, Jakob FM, Saugel B, Cappello C, Paschos E, Hollweck R, Hickel R, Brand 
K. Effect of ozone on oral cells compared with established antimicrobials. Eur J 
Oral Sci. 2006 Oct;114(5)”435-50 
31) Azarpazhooh A, Limeback H. The application of ozone in dentistry: A systematic 
review of literature. J Dent. 2008 Feb;36(2):104-16. Doi: 
10.1016/j.dent.2007.11.008. Epub 2007 Dec 31 
